The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
1 other identifier
observational
500
1 country
1
Brief Summary
We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 19, 2006
CompletedFirst Posted
Study publicly available on registry
July 20, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedJuly 6, 2011
June 1, 2011
July 19, 2006
July 3, 2011
Conditions
Keywords
Eligibility Criteria
patients admitted to tertiary hospital
You may qualify if:
- treatment with enoxaparin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, 91120, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mordechai Muszkat, MD
Hadassah University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 19, 2006
First Posted
July 20, 2006
Study Start
July 1, 2006
Study Completion
October 1, 2015
Last Updated
July 6, 2011
Record last verified: 2011-06